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Extramedullary Multiple Myeloma in the Head and Neck:
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aJoint Department of Medical Imaging, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
bDivision of Neuroradiology, Department of Medical Imaging, Princess Margaret Hospital, Toronto, Ontario, CanadaKey Words: Multiple myeloma; Atypical presentation; Head and neckPlasma cells are a type of white blood cell that arise from
B lymphocytes and play an essential role in the immune
response by secreting immunoglobulins. In the case of
plasma cell tumours, they are typically formed from clones
of a single cell and exhibit characteristic secretion of para-
proteins. Multiple myeloma (MM) is the most common
plasma cell neoplasm, which commonly presents with
disseminated bone marrow involvement. A solitary plasma-
cytoma is a localized tumour of plasma cells that can arise in
bone or soft tissue. A plasmacytoma can represent the first
manifestation of a generalized myeloma or remain an inde-
pendent localized neoplasm. Extramedullary plasmacytomas
(EMP) can arise in various areas in the body. Approximately
80% of EMP arise in the head and neck, but this still
constitutes less than 1% of head and neck malignancies.
Common locations include the nasal cavity, paranasal
sinuses, and nasopharynx. EMP shows a male predilection of
3:1 and a peak incidence in the fifth and seventh decades. We
present 6 cases of MM that involve various sites in the head
and neck.
Case PresentationCase 1This is a 62-year-old man with a 4-year history of MM.
The patient had a history of thoracic spine involvement
that required surgical decompression. The patient* Address for correspondence: Eugene Yu, MD, Princess Margaret
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Canada.
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http://dx.doi.org/10.1016/j.carj.2012.08.002subsequently developed multiple soft-tissue masses in the
head and neck, and a tingling sensation in the cheek.
Magnetic resonance and computed tomographic imaging
(Figure 1) revealed a mass in the right masticator space, with
involvement of the pterygopalatine fossa. Infiltration of the
thyroid ala was also present. Tissue sampling confirmed the
presence of myeloma.Case 2A 44-year-old woman presented 5 years earlier with
a myelomatous lesion in the C4 vertebra. The patient then
developed multiple lesions in the head and neck, including
the masticator space, with contiguous involvement of the
maxillary sinus, orbit, and clivus (Figure 2). The patient was
treated with radiation therapy.Case 3This 52-year-old man presented with right-sided neck
adenopathy. The clinical examination also revealed the
presence of a mass at the base of the tongue. Computed
tomographic imaging was performed to localize the extent of
disease (Figure 3, A-D). Pathology revealed the presence of
atypical plasma cells. Kappa staining showed homogeneous
uniform positivity, which confirmed a monoclonal prolifer-
ation consistent with a diagnosis of MM (Figure 3, E and F).Case 4A 66-year-old man with a 4-year history of MM that
initially presented as a T6 spinal lesion. The patient subse-
quently presented with a cough and dysphonia. Computedll rights reserved.
Figure 1. (A, B) Coronal and (C-E) axial unenhanced T1-weighted images, and (F-I) axial contrast-enhanced T1-weighted images, demonstrating the presence
of a mass lesion that involves the right masticator space. There is also infiltration of the floor of the right middle cranial fossa. Tumour is also present within the
right sphenoid sinus. (J-K) Contrast-enhanced axial computed tomographic imaging, showing abnormal infiltration into the thyroid cartilage ala.
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Figure 2. (A) Axial bone algorithm image of the skull base, showing a lytic lesion within the clivus. (B) A coronal computed tomographic image showing a soft
tissue mass located inferiorly in the left orbit in intimate contact with the inferior rectus musculature. (C, D) Axial postgadolinium-enhanced imaging
demonstrating enhancing tissue in the clivus, left orbit, as well as a mass that involves the right greater sphenoid wing.
Figure 3. (A-D)Contrast computed tomography study, showing a lobulatedmass involving the base of the tongue, aswell as right neck adenopathy in levels II and III. (E)
Hematoxylin and eosin stained slide from a tongue biopsy (100magnification) demonstrating atypical plasma cells beneath squamous epithelium. (F) KAPPA staining
(100magnification) revealed uniform positivity consistent with amonoclonal plasma cell proliferation. This figure is available in colour online at http://carjonline.org/.
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Figure 4. (A-D) Contrast computed tomography (CT) study in the axial and (E) sagittal planes showing the presence of a circumferential mass in the subglottic
larynx seen as a soft tissue density filling the subglottis and extending into the proximal trachea. There is also evidence of cricoid erosion. (E) Sagittal contrast
CT shows abnormal increased soft tissue density filling the subglottis.
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Histopathology confirmed a diagnosis of myeloma.Case 5An 87-year-old man with a 4-year history of MM subse-
quently presented with right eye pain, decreased visual
acuity, and a sixth nerve palsy. Imaging revealed an infil-
trative mass that involved the right cavernous sinus and
sphenoid sinus (Figure 5, A-D).Case 6This is a 47-year-old man with a history of human
immunodeficiency virus, and hepatitis A, B, and C. The
patient developed a sensation of pressure in the left maxillary
sinus and double vision. Imaging revealed a large mass in the
left maxillary sinus with extension into the adjacent nasalcavity and retroantral region. A second focus of disease was
also present in the left frontal sinus (Figure 6, A-E). Patho-
logic assessment supported a diagnosis of MM (Figure 6F).
Discussion
MM is the most common plasma cell neoplasm. It
accounts for 10% of hematologic malignancies and 1% of
malignant diseases [1]. In 2010, an estimated 2300 new cases
of MM were diagnosed in Canada [2], which reflects an
annual incidence rate of 5 cases per 100,000. Rarely pre-
senting before the age of 40 years, MM is typically diag-
nosed in older populations, with a median age of 65 years
[1]. Incidence rates of MM reflect a male predilection and are
highest in African American populations [3]. Symptomatic
MM presents clinically with disseminated involvement,
serum monoclonal immunoglobulins (M protein), lytic bone
lesions, anemia, renal impairment, and hypercalcemia. In
Figure 5. (A-C) Gadolinium-enhanced axial and (D, E) coronal T1-weighted images, and (F) an axial T2-weighted image, showing the presence of abnormal
thickening and enhancement of the right cavernous sinus, as well as a contiguous mass within the right sphenoid sinus.
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benign stage referred to as monoclonal gammopathy of
undetermined significance or at an asymptomatic premalig-
nant stage called smoldering MM. Both monoclonal
gammopathy of undetermined significance and smoldering
MM carry a high risk of progression to malignant disease.
Progression of MM is dependent on changes in the bone
marrow microenvironment, which produces factors that
support proliferation and survival. In most cases, this
confines the disease to the bone marrow; however, EMP canarise in various areas in the body. In one study of 1003
patients with MM, 7% of patients had extramedullary
involvement at the time of diagnosis and 6% of patients
developed soft-tissue EMP at 30-month follow-up. Approx-
imately 80% of EMPs arise in the head and neck, but EMPs
still constitute less than 1% of head and neck malignancies
[4]. Common locations include the nasal cavity, paranasal
sinuses, and nasopharynx.
It is theorized that novel therapeutic agents and treatment
regimens combined with longer survival times in patients
Figure 6. (A) Unenhanced axial T2-weighted, and (B,C) post-gadolinium enhanced coronal and (D,E) axial imaging, showing a large mass with the epicentre in
the left maxillary sinus. The expansile mass has breached the walls of the sinus to infiltrate into the premaxillary and retroantral areas, as well as the adjacent
nasal cavity. (B,C) There was also a second focus of disease within the left frontal sinus. (F) Hematoxylin and eosin stained slide (200magnification) showing
an abundance of abnormal atypical plasma cells. Immunohistochemistry showed features consistent with plasma cells given the positive reaction to CD138,
MIB-1 and nonreactivity towards CD45, CD20, EBER, and keratin. This figure is available in colour online at http://carjonline.org/.
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occurrence of atypical extramedullary disease that was not
seen in the past due to poor prognosis and limited treatment
options. In one study [5], an increase in extramedullary
disease from 5% to 12% at relapse was observed in patients
treated with high-dose therapy compared with those treated
with conventional dose therapy. This is likely due to the
selection of resistant clones after intensified therapy. In other
reports, extramedullary disease has been associated with the
use of thalidomide, which induces dedifferentiation andmodification of surface adhesion molecules. This ultimately
allows malignant cells to escape the bone marrow microen-
vironment and invade other tissues [6,7]. Thus, as treatment
continues to advance and MM becomes a progressively more
chronic disease, extramedullary progression and relapse will
become a more important consideration in the management
of patients with MM.
Our pictorial essay presents 6 cases of atypical extra-
medullary recurrence of MM in the head and neck. These
atypical presentations have increased in occurrence in recent
369Multiple myeloma in the head and neck / Canadian Association of Radiologists Journal 64 (2013) 363e369years due to improved treatment regimens and longer
survival times. On radiologic examination, it is important to
recognize that MM can present in rather unusual locations in
the head and neck, and can mimic more common entities
such as squamous cell carcinoma and lymphoma both on
imaging as well as on clinical examination. Imaging is vital
in assessing disease location and extent (staging) as well as
guiding locations for tissue sampling. The latter will be
important in establishing the correct diagnosis and thus
directing treatment.
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